Former Premier League striker Dave Kitson has announced his bid to end Gordon Taylor's near four-decade run as chief executive of the Professional Footballers' Association (PFA).

Arsenal's head of football Raul Sanllehi has suggested that transfers are not a priority this summer in call with club staff.​

Juventus' chief football officer Fabio Paratici has warned that the impacts of the Covid-19 crisis will leave fewer clubs able to meet the financial demands of high-level players such as Manchester United midfielder Paul Pogba.

Aston Villa chief executive Christian Purslow has compared the Premier League's 'Project Restart' planning to the Brexit process.

League Managers Association chief executive Richard Bevan has warned the Premier League season could be cancelled if clubs do not agree to playing at neutral grounds.

With the Premier League searching for viable options to finish the current campaign, deputy chief constable Mark Roberts believes those complaining about the finer details must "get a grip".

Liverpool remain keen on signing Kosovo winger Milot Rashica, the president of the country's Football Federation has claimed.

Louis Van Gaal has claimed that Tottenham chairman Daniel Levy left his house in a car boot to avoid the local press after holding talks about becoming the club's new manager in 2014.

The 46-year-old actress is now revealing the agony she went through before receiving a diagnosis of multiple sclerosis (MS) last August."Ever since my son was born, I was in an MS flare-up and didn't know, and I was giving it everything to seem normal," Blair told Robin Roberts in an interview that aired Tuesday on "Good Morning America." "And I was self-medicating when he wasn't with me. Blair recalled that she would get so fatigued prior to her diagnosis that she would need to pull over to take a nap after dropping her son, now 7, off at his school one mile away from their home. During her interview with "GMA" at her Los Angeles home, Blair was in an "exacerbation" of MS, or an attack that causes new symptoms or the worsening of existing symptoms.

Senate Minority Leader Chuck Schumer (D-NY) on Monday called for ousted Secret Service Director Randolph “Tex” Alles to testify before...

Join POLITICO for a series of virtual briefings and audio teleconferences to learn the latest updates on coronavirus and its impacts.

FDA Commissioner Stephen Hahn is asymptomatic and tested negative for the virus on Friday, one senior administration official said.

Zerhouni is thought to be the favorite, said two people, and one person said that Azar personally prefers Zerhouni for the role.

NSW Police has refused to reveal if defence lawyers are being spied on with electronic surveillance as part of criminal investigations.

The money earmarked for sports will go to national and provincial organizations, Canadian sport institutes and Indigenous sport groups.

The ATP, WTA, ITF and four Grand Slam events have created a program to support players affected by the sport's coronavirus-related shutdown.

Chargers open NFL season on road against Cincinnati Bengals and then make SoFi Stadium debut in Week 2 against defending Super Bowl champion Kansas City Chiefs.

He will receive nearly 1.69 million stock options priced at 350.02 dollars (£285).

Mark Roberts believes those who say the proposal compromises the integrity of the league need to look at the broader context.

As the televisual equivalent of a mood ring, the White House briefings are extremely useful. As a vehicle for delivering information, not so much.

Trump's decision to air the selectively edited video clips led major US television networks to quickly cut away from his daily coronavirus briefing. 

The story about TV networks cutting away from the US President's press briefing generated the most online discussion with our readers this week.

Consumer advocates call for a ban on short-term loans because of concerns loan sharks are using text messages to target vulnerable people affected by the coronavirus pandemic.

A First Nations financial organization in the Atlantic region is voicing concern over the exclusion of band-owned, non-taxable businesses in federal financial relief programs during the COVID-19 pandemic.

THE chief executive of troubled baby formula maker Bellamy’s is stepping down in the wake of its disastrous share price plunge.

UN Secretary-General Antonio Guterres says the coronavirus pandemic keeps unleashing "a tsunami of hate and xenophobia, scapegoating and scaremongering" and appealed for "an all-out effort to end hate speech globally".The UN chief...

Ahead of Monday's crunch meeting of top-flight shareholders, the Hornets have joined Brighton and Aston Villa in making their opposition to the current 'Project Restart' plans clear

It is very unlikely Australian sports fans will be able to pack out stadiums on grand final weekend, even if the plan to lift restrictions is successful, Deputy Chief Medical Officer Paul Kelly says.

The IOC and Olympics organisers have reset the clock on the Tokyo games for a year-long delay from the intended opening — but they warn there is no blueprint for getting to the new start line.

The former Australian skipper says he thinks the Twenty20 World Cup in Australia will be postponed if fans aren't allowed to attend matches because of the COVID-19 pandemic.

Todd Greenberg resigns with immediate effect after four years leading the NRL, in a decision the sporting body says was mutually agreed.

Raelene Castle says "the sport is bigger than any one individual", resigning after the Rugby Australia board told her it wanted "clear air" without her as chief executive.

At the annual invite-only 2020 Enterprise Retreat in Half Moon Bay, CA, 100 enterprise leaders gathered in a social-media free environment, to network, discuss hot topics and dive into provocative, insightful off-the-record 'State of the Union' presentations. This report details their findings.

Keep on reading: The Enterprise 2020 Report: Software CEO Briefing

The Advanced Medical Association (AdvaMed) has requested the United States Trade Representative (USTR) provides additional tariff exclusions for medical devices, components and supplies coming from China which are necessary to help with Covid-19.

House Energy and Commerce Committee Chairman Frank Pallone Jr. (D-NJ) and Senate Finance Committee Ranking Member Ron Wyden (D-OR) called on the Trump administration to address the lack of financial relief for Medicaid providers fighting the COVID-19 pandemic. The two Committee leaders voiced concerns that, to date, roughly $70 billion has been distributed to health care providers under the CARES Act in a way that discriminates against Medicaid-dependent health care providers. “HHS’s continued neglect for the needs of Medicaid-dependent providers struggling to deal with the COVID-19 crisis is unacceptable,” the members wrote. “The country is in the middle of a pandemic. The Medicaid program is a first responder, and the providers it relies on must be treated with equity. At a bare minimum that should include expeditious access to the [provider fund] as intended by Congress.”  The Provider Relief Fund that Congress created as a part of the CARES Act, within the Public Health and Social Services Emergency Fund (PHSSEF), was intended to support health care providers including those who participate in Medicare and Medicaid. However, to date only Medicare-enrolled providers have been able to access funds, and these funds are being allocated according to a methodology that rewards providers with high levels of privately-insured individuals while providers supporting the safety net are left waiting. This imbalance discriminates against critical health care providers that primarily service the Medicaid population, such as frontline hospitals, nursing homes and home-based providers, behavioral health providers, maternal health care providers and pediatricians. In the letter, sent to Health and Human Services (HHS) Secretary Alex Azar, Pallone and Wyden called on the Trump administration to describe how much funding will go to Medicaid-dependent providers and the steps it has taken to understand the needs of these providers during the pandemic. The full letter is available here. ###

Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ) and Ways and Means Chairman Richard E. Neal (D-MA) sent a letter to Health and Human Services (HHS) Secretary Alex Azar and Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma today raising a series of concerns over the methodology used to distribute and the lack of transparency into how COVID-19 relief funds and loans for health care providers are being spent.  “We write to raise serious concerns about the Provider Relief Fund and the Accelerated and Advance Payment Programs,” Pallone and Neal wrote.  “With respect to each, we are concerned about the lack of transparency with Congress and the American people about how funds are being spent or loans are being made.  We also have grave concerns regarding the methodology being used to distribute $175 billion Congress appropriated for the Provider Relief Fund.” The Chairmen’s letter documents concerns with how the programs are being run, in particular the Administration’s methodologies for distributing funding that has shortchanged a number of critical providers and makes clear that more transparency is needed for Congress to accurately assess the ongoing needs of health care providers as the COVID-19 crisis unfolds. “The Administration’s efforts to establish the Provider Relief Fund to date has been at best, a series of missteps, and at worst, a disregard of Congress’ intent for the program,” Pallone and Neal continued in their letter. Pallone and Neal wrote that when Congress passed the CARES Act, it was clear that the funding provided to HHS for the Provider Relief Fund was for the express purpose, “to prevent, prepare for, and respond to coronavirus.”  The two Chairs voiced concern that some of the funding formulas adopted to date fail to target funding based on the statutory framework relating to COVID-19 driven costs.  In fact, the Chairs write that the level of funding appears to be, “completely disconnected from need.” The Chairmen requested an immediate response from HHS regarding documents and information pertaining to the Provider Relief Fund and the Accelerated and Advanced Payment Program.  Pallone and Neal also wrote that if HHS is unable to immediately provide the information, it should provide a timeline of when the Committees would receive the requested information. While recognizing the incredible demands on the Department at this difficult time, the Chairmen emphasized that, “This crisis demands that we work swiftly and based on the best data available.  Currently, despite repeated requests, this Administration has prevented Congress from obtaining the data that the Department has available on funding for our health care system, data that is necessary to inform near future legislation.  We look forward to receiving this information so that we can conduct the business the American people expect of us.  We look forward to having you join us at the earliest possible date in each of our Committees to discuss these and other COVID-related issues.” To read the full letter, click HERE. ###

Chief Executive Mike Thompson is to retire from his role at the Association of the British Pharmaceutical Industry (ABPI) by the end of this year.

His decision to leave the association marks the end of a three-year run beginning in March 2016, when stepped in to take up the mantle from Alison Clough, who had served as the acting Chief Executive for much of 2015.

read more

Dr Reshma Kewalramani has been made the new Vertex CEO.

Vertex’s Chief Medical Officer Dr Kewalramani will succeed current CEO Jeffrey Leiden who has is now stepping aside from the role after seven years as Chief executive at the Boston-based firm. In stepping down Leiden will serve as executive chairman until the first quarter of 2023.     

Fourty-six year old Dr Kewalramani, who has been at Vertex since 2017, will thus become the first woman to head the firm. Prior to joining Vertex, Kewalramani spent more than 12 years at Amgen.

read more

Immunotherapy-focused pharmaceutical company Midatech Pharma has appointed Stephen Stamp as Chief Financial Officer (CFO) with immediate effect.

He will be replacing Nick Robbins-Cherry, who has stepped down after five years since joining in 2014. Robbins will nevertheless remain at Midatech until October to facilitate Stamp’s handover in an orderly fashion.

Stamp has most recently served as CEO of pharmaceutical firm Ergomed for two years, stepping down in January citing health reasons. Prior to this he was CFO at Ergomed for a year beginning in 2016.

read more

Chief Executive of Gulf Pharmaceutical Industries, Jerome Carle, is stepping down from his post at the United Arab Emirates drug manufacturer facing mounting pressure.

Julphar, one of the biggest generic drugs manufacturers in the Middle East and North Africa said Jerome Carle has “tendered his resignation” and the board has accepted it. His last working day will be December 8th.

read more

Sir Mark Walport, Chief Executive of UK Research and Innovation (UKRI), the national funding agency responsible for science and research investment in the UK, has announced he is to retire for the role next year.

The decision to leave the organisation in 2020 will mark the end of a three-year tenure at its helm, beginning in 2017 when Walport was appointed to “create a single, ambitious organisation and provide the UK with a world class funding system to keep it at the forefront of global research and innovation”.

read more

London consultant and public health professor, Chris Whitty, has begun his role as England’s Chief Medical Officer, taking over from Dame Sally Davies, who has now stepped down from the position.

Whitty has served as the Department of Health and Social Care’s Chief Scientific Adviser since 2016 and was announced as Dame Sally Davies successor earlier in June this year.

read more

Gilead Sciences have announced that Merdad Parsey will join the company as Chief Medical Officer, effective November 1st.

Dr Parsey will be responsible for and oversee the company’s global clinical development and medical affairs organisations – reporting directly to Daniel O’Day, Gilead’s Chairman and Chief Executive Officer.

read more

The Association of the British Pharmaceutical Industry (ABPI) has appointed Dr Richard Torbett as its new Chief Executive. He will assume the position on 1 January 2020.

The appointment comes after his predecessor, Mike Thompson, stepped down in June. He had served in the role since March 2016. Torbett was unanimously selected by the ABPI board after an external recruitment process with an executive search agency.

read more

Saniona has announced that Rami Levin will take over as the Chief Executive Officer of the company as it seeks to transition into a fully-fledge biopharmaceuticals company, with a focus on rare diseases.

Levin was appointed by the Board of Directors and the company’s founders. His appointment takes immediate effect.

read more

Ipsen has named Dr Steven Hildemann as its new Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs and Pharmacovigilance.

In his new role, which begins on 1 March 2020 and will be based in Paris, he will report directly to Ipsen CEO Aymeric Le Chatelier. His remit will include the provision of medical strategy to the company’s scientific, clinical and business teams, while also working in tandem with its R&D operations to design and direct clinical trials efforts to generation of post-launch data.

read more

Khondrion has revealed that Dr Rob van Maanen has joined the company as its new Chief Medical Officer (CMO).

Dr van Maanen’s career has spanned more than 20 years and seen him take on roles at major industry names such as Roche, Astellas and Eisai. In the role, he will manage the company’s medical operations and clinical strategy.

read more

Galecto has announced Bertil Lindmark as their new Chief Medical Officer. He began his posting on 1 February 2020.

Lindmark joins from the eTheRNA immunotherapies, which is a Belgian mRNA immunotherapy company. He has also had an extensive and successful career in the pharmaceutical industry.

read more